While in the general population, the association between vWF and thromboembolic cardiovascular events is weak, in patients with a pre-existing cardiovascular disease, the level of vWF can be used to predict adverse cardiovascular events [31]. The gene discussed is VWF; the disease is cardiovascular disorder.